Table of Contents
Chromatography Research International
Volume 2013 (2013), Article ID 941429, 6 pages
http://dx.doi.org/10.1155/2013/941429
Research Article

Stress Degradation Studies on Flupirtine Maleate Using Stability-Indicating RP-HPLC Method

Department of Pharmaceutical Analysis, Hindu College of Pharmacy, Amaravathi Road, Guntur 522002, India

Received 2 September 2013; Accepted 31 October 2013

Academic Editor: Toyohide Takeuchi

Copyright © 2013 Singaram Kathirvel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. P. Aneesh and D. Amal, “Method Development and Validation for the estimation of flupirtne maleate in bulk and pharmaceutical dosage form by UV- Visible spectrophotometry,” International Research Journal of Pharmacy, vol. 2, no. 12, pp. 179–182, 2011. View at Google Scholar
  2. R. Jakob and J. Krieglstein, “Influence of flupirtine on a G-protein coupled inwardly rectifying potassium current in hippocampal neurones,” British Journal of Pharmacology, vol. 122, no. 7, pp. 1333–1338, 1997. View at Google Scholar · View at Scopus
  3. J. Devulder, “Flupirtine in pain management: pharmacological properties and clinical use,” CNS Drugs, vol. 24, no. 10, pp. 867–881, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Klawe and M. Maschke, “Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound,” Expert Opinion on Pharmacotherapy, vol. 10, no. 9, pp. 1495–1500, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Xue-yan, S. Yi, C. Xiu-feng, L. Xiao-wei, and C. Ruo-bing, “Determination of dissociation constant for Flupirtine by UV,” West China Journal of Pharmaceutical Sciences, vol. 25, no. 3, 2010. View at Google Scholar
  6. W. Hai-yang, Z. Yan-ling, and N. Lei, “Determination of flupirtine maleate capsules by RP-HPLC,” Qilu Pharmaceutical Affairs, vol. 29, no. 10, 2010. View at Google Scholar
  7. X. Chen, D. Zhong, H. Xu, B. Schug, and H. Blume, “Simultaneous determination of flupirtine and its major active metabolite in human plasma by liquid chromatography-tandem mass spectrometry,” Journal of Chromatography B, vol. 755, no. 1-2, pp. 195–202, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Long-xing, X. Dong-ya, and G. Tao, “Determination of the concentration of flupirtine in human plasma by RP-HPLC,” Journal of Shenyang Pharmaceutical University, vol. 27, no. 07, pp. 559–562, 2010. View at Google Scholar
  9. K. Kandasamy, V. S. Gowdra, H. Nammalvar, and A. K. K. S. Govindarajan, “Bioanalytical method development, validation and quantification of flupirtine maleate in rat plasma by liquid chromatography-tandem mass spectrometry,” Arzneimittel-Forschung/Drug Research, vol. 61, no. 12, pp. 693–699, 2011. View at Google Scholar · View at Scopus
  10. ICH Topic Q2 (R1), Validation of Analytical Procedures: Methodology, The European Agency for the Evaluation of Medicinal Products, Geneva, Switzerland, 2005.
  11. ICH (QIB), “Harmonized tripartite guideline, stability testing: photostability testing of new drug substances and products,” in Proceedings of the International Conference on Harmonization, Geneva, Switzerland, November 1996.